- ►annals.org [PDF] CM Clark, JHT Karlawish - Annals of internal medicine, 2003 - Am Coll Physicians Alzheimer disease is a complex neurodegenerative dementing ill- ness. It has
become a major public health problem because of its increasing prevalence, long
duration, high cost of care, and lack of disease-modifying therapy. Over ... Cited by 118 - Related articles - BL Direct - All 7 versions
M Saeed, PM Frossard, HS Parvez - Biogenic Amines, 18, 2004 - ingentaconnect.com Abstract—Alzheimer's disease (AD) is the most common cause of dementia
worldwide. It causes major debility for the elderly with medical, social and
economic implications. The pathology of AD was described in early twentieth ... Related articles - BL Direct
[CITATION] Alzheimer's disease: from bench to bedside
- ►annals.org [PDF] J Karlawish, CM Clark - Annals of internal medicine, 2004 - Am Coll Physicians TO THE EDITOR: The review of smallpox vaccination risks and public policy by
Lane and Goldstein (1) was timely and informative. However, their recommendation
for smallpox-infected patients to wear the N95 respirator in isolation ... Cited by 32 - Related articles - BL Direct - All 11 versions
MA Moyad - Seminars in urologic oncology, 1999 - 万方数据资源系统 Although prostate cancer is the number one diagnosed cancer in men, the
importance of emphasizing and preventing other common diseases after diagnosis
is essential. For example, heart disease still remains the number one cause ... Cited by 6 - Related articles - BL Direct - All 4 versions
H Feldman, S Gauthier, J Hecker, B Vellas, B … - Journal of the American Geriatrics Society, 2003 - interscience.wiley.com *Division of Neurology, UBC Hospital, Clinic for Alzheimer's Disease and Related
Disorders, Vancouver, British Columbia, Canada; † Alzheimer Disease Research
Unit, McGill Center for Studies in Aging, Verdun, Quebec, Canada; ‡ ... Cited by 103 - Related articles - BL Direct - All 6 versions
B Vellas, S Andrieu, C Sampaio, G Wilcock - Lancet neurology, 2007 - Elsevier After symptomatic treatments, the new target for therapeutic approaches in
Alzheimer's disease is the development of disease-modifying drugs. The concept
of disease modification in Alzheimer's disease is controversial and the ... Cited by 41 - Related articles - All 6 versions
JA Molina, FJ Jimenez-Jimenez, A Hernanz, E … - Journal of Neural Transmission, 2002 - Springer Departments of 1 Neurology, and 4 Biochemistry, Hospital Universitario Doce de
Octubre, 2 Department of Neurology, Hospital “Príncipe de Asturias”,
Universidad de Alcalá de Henares, and 3 Department of Biochemistry, Ciudad ... Cited by 9 - Related articles - BL Direct - All 4 versions
RS Doody, DS Geldmacher, B Gordon, CA … - Archives of Neurology, 2001 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 171 - Related articles - BL Direct - All 4 versions
- ►oxfordjournals.org HW Klafki, M Staufenbiel, J Kornhuber, J … - Brain, 2006 - Oxford Univ Press Alzheimer's disease is an age-related progressive neurodegenerative disorder
with an enormous unmet medical need. It is the most common form of dementia
affecting 5% of adults over 65 years. In view of our ageing society the ... Cited by 80 - Related articles - BL Direct - All 8 versions
